Use of Right Orbitofrontal Repetitive Transcranial Magnetic Stimulation (rTMS) Augmentation For Treatment-Refractory Obsessive-Compulsive Disorder With Comorbid Major Depressive Disorder

SOURCE: Psychiatry Research. 317:114856, 2022 Nov.

AUTHORS: Tadayonnejad R; Wilson AC; Chu SA; Corlier J; Citrenbaum C; Ngo TDP; Hovhannisyan E; Ginder ND; Levitt JG; Wilke SA; Krantz D; Bari AA; Leuchter AF

ABSTRACT: We examined the safety and efficacy of repetitive Transcranial Magnetic Stimulation (rTMS) of the right orbitofrontal cortex (OFC) in patients with refractory obsessive-compulsive disorder (OCD) and comorbid Major Depressive Disorder. All participants (n = 26) received excitatory stimulation of the left dorsolateral prefrontal cortex followed by inhibitory stimulation of bilateral supplementary motor area for 10 sessions. In 18 patients with poor early OCD response, treatment was augmented with OFC inhibitory stimulation after the tenth treatment session. Augmentation with OFC stimulation was well-tolerated, and associated with further alleviation of both OCD and depression symptoms, particularly in individuals with more severe illnesses.